MedPath

Detection of buried Barrett glands after Radiofrequency Ablation (RFA) with Volumetric Laser Endomicroscopy (VLE); a histopathology correlation study

Completed
Conditions
1) Buried Barrett's 2) Occult buried glandular mucosa
10017990
Registration Number
NL-OMON38462
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

- Age > 18 * 80 years;
- Patients post RFA treatment with 100% endoscopic regression of Barrett*s epithelium;
- Minimum circumferential Barrett*s extent of 2 cm prior to ablation therapy;
- Signed informed consent.

Exclusion Criteria

- Presence of significant stenosis;
- Presence of erosive esophagitis;
- Inability to undergo ER and/or obtain biopsies (e.g. due to anticoagulation, coagulation disorders, varices);
- Unable to provide signed informed consent.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Presence of structures suggesting BB on VLE;<br /><br>- VLE characteristics of buried glands (e.g. sparsely distributed<br /><br>hyposcattering structures underneath NSE with various sizes and shapes)<br /><br>- Number of glands<br /><br>- Size of glands<br /><br>- Location of glands from GEJ<br /><br>- Depth level of glands<br /><br><br /><br>Presence of structures suggesting of BB in ER specimens and, if present:<br /><br>- Number of glands<br /><br>- Size of glands<br /><br>- Location of glands from GEJ<br /><br>- Depth level of glands<br /><br>- Histology: Intestinal metaplasia, Dysplasia<br /><br><br /><br>Correlation of OFDI images with corresponding histology of ER specimen</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>-</p><br>
© Copyright 2025. All Rights Reserved by MedPath